International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.

Antimicrobial Agents and Chemotherapy
O LortholaryFrench Mycoses Study Group

Abstract

The outcomes for 73 invasive fusariosis patients treated with voriconazole were investigated. Patients with proven (n = 67) or probable (n = 6) infections were identified from the voriconazole clinical database (n = 39) and the French National Reference Center for Mycoses and Antifungals database (n = 34). Investigator-determined success was a complete or partial response. Survival was determined from day 1 of voriconazole therapy to the last day known alive. Patients were 2 to 79 years old (median, 43 years), and 66% were male. Identified Fusarium species (62%) were F. solani, F. moniliforme, F. proliferatum, and F. oxysporum. Underlying conditions analyzed included hematopoietic stem cell transplant (HSCT; 18%), hematologic malignancy (HM; 60%), chronic immunosuppression (CI; 12%), or other condition (OC; 10%). Infection sites were brain (5%), disseminated excluding brain (67%), lungs/sinus (15%), and other (12%). Most patients (64%) were or had recently been neutropenic (<500 cells/mm(3)). Therapy duration was 1 to 480 days (median, 57 days), with a 47% success rate. Baseline neutropenia impacted success adversely (P ≤ 0.03). Success varied by underlying condition (HSCT, 38%; HM, 45%; CI, 44%; OC, 71%) and infection site (br...Continue Reading

References

Feb 24, 2001·Medical Mycology·J I Pitt
Apr 3, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P Sampathkumar, C V Paya
Sep 25, 2002·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Issam RaadKenneth Rolston
Apr 26, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John R PerfectElizabeth Johnson
Sep 23, 2003·The Journal of Burn Care & Rehabilitation·Barbara A Latenser
Jan 8, 2004·Journal of Chemotherapy·H A TorresD P Kontoyiannis
Jan 30, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M C Dignani, E Anaissie
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marcio NucciElias Anaissie
Apr 6, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John R Perfect
Apr 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Issam I RaadDimitrios P Kontoyiannis
Nov 14, 2006·Eye & Contact Lens·Sandhya A IyerRyan C Wagoner
Jan 16, 2007·Antimicrobial Agents and Chemotherapy·Mónica AzorJosep Guarro
Oct 16, 2007·Clinical Microbiology Reviews·Marcio Nucci, Elias Anaissie
May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben De PauwUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Jul 22, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brahm H SegalBen E De Pauw
Jan 1, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D NeofytosK Marr
Mar 26, 2009·The Journal of Antimicrobial Chemotherapy·Mónica AzorJosep Guarro
Feb 9, 2010·The Journal of Infection·Marcela CampoDimitrios P Kontoyiannis

❮ Previous
Next ❯

Citations

Jul 12, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A DebourgogneM Machouart
Aug 13, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J Guarro
Oct 16, 2012·Current Infectious Disease Reports·Perrine ParizeOlivier Lortholary
Apr 16, 2011·The Journal of Antimicrobial Chemotherapy·Josep Guarro
Jun 15, 2011·Current Opinion in Infectious Diseases·Victor E Mulanovich, Dimitrios P Kontoyiannis
Feb 18, 2012·Respirology : Official Journal of the Asian Pacific Society of Respirology·Jeannina A Smith, Carol A Kauffman
Sep 29, 2012·Pediatric Dermatology·Lucero Noguera MorelRaúl De Lucas Laguna
Nov 9, 2011·Antimicrobial Agents and Chemotherapy·William W Hope
Feb 6, 2013·Antimicrobial Agents and Chemotherapy·William W HopeMichael N Neely
Dec 30, 2011·Journal of Clinical Microbiology·Anna Maria TortoranoGiuliana Lo Cascio
Jun 23, 2011·Infection and Drug Resistance·Asma Lat, George R Thompson
Mar 4, 2011·Medical Mycology·Melanie W PoundRichard H Drew
Nov 6, 2012·Revista brasileira de hematologia e hemoterapia·Marcio Nucci
Dec 20, 2014·Scientifica·Yoann Crabol, Olivier Lortholary
May 6, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A M TortoranoUNKNOWN ECMM Working Group
Jun 22, 2012·Infection·P TrokeO Lortholary
Apr 7, 2015·Expert Review of Anti-infective Therapy·David AllenJohn Perfect
Aug 4, 2011·Expert Review of Anti-infective Therapy·Morena CairaLivio Pagano
Jun 4, 2013·Expert Opinion on Pharmacotherapy·Athanasios TragiannidisAndreas H Groll
Jan 23, 2016·IDCases·Matthew B Lockwood, Juan Carlos Rico Crescencio
May 30, 2013·Infectious Disease Clinics of North America·Shmuel Shoham
Mar 31, 2012·Enfermedades infecciosas y microbiología clínica·María Carmen FariñasCarlos Armiñanzas
Nov 8, 2011·Médecine et maladies infectieuses·O EpaulardO Lortholary
Mar 8, 2013·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S HuprikarUNKNOWN AST Infectious Diseases Community of Practice
Jun 4, 2014·Transplant Infectious Disease : an Official Journal of the Transplantation Society·J M TerasakiV G Valentine
Nov 24, 2012·Journal of Chemotherapy·Małgorzata MikulskaClaudio Viscoli
Apr 8, 2014·International Journal of Medical Microbiology : IJMM·Yasunori MuraosaKatsuhiko Kamei
May 9, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J GavaldàM Cuenca-Estrella
Aug 25, 2015·Current Fungal Infection Reports·Anne D van DiepeningenCees Waalwijk
May 6, 2015·Revista iberoamericana de micología·Juan Carlos García-RuizMaría-Dolores Moragues
May 23, 2015·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B Dalyan CiloA D van Diepeningen
Oct 15, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M NucciE Anaissie
Sep 26, 2015·Journal of the Pediatric Infectious Diseases Society·Kevin L SchwartzShaun K Morris
Feb 10, 2011·Virulence·Maged MuhammedEleftherios Mylonakis
Apr 9, 2013·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Shojiro InanoNobuyoshi Arima
Jun 12, 2013·Clinica Chimica Acta; International Journal of Clinical Chemistry·Yosuke SuzukiJun-ichi Kadota

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The New England Journal of Medicine
François BlotGérard M Nitenberg
Antimicrobial Agents and Chemotherapy
Peter TrokeGlobal Scedosporium Study Group
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
O LortholaryFrench Mycosis Study Group
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Yasmine NivoixRaoul Herbrecht
© 2021 Meta ULC. All rights reserved